Latest News
Press Releases
Feb 17, 2026
Mandara Biopharma Receives FDA Approval to Launch Their Clinical Trials for Alzheimer’s Agitation
Jan 12, 2026
Mandara Biopharma Files IND with the FDA to Advance Dronabinol Oral Solution Formulation for Alzheimer’s Agitation